CellFE grabs $3.6 mln
CellFE Inc, a developer of a microfluidics-based device to deliver gene-editing molecules, has raised $3.6 million in funding.
CellFE Inc, a developer of a microfluidics-based device to deliver gene-editing molecules, has raised $3.6 million in funding.
Copyright PEI Media
Not for publication, email or dissemination